Background
A Top 10 global pharmaceutical company conducting a multi-centre oncology trial in China.
The challenge
The sponsor required large, consistent batch sizes of an EU-authorised oncology product to support a complex trial in China. Local sourcing constraints, strict regulatory demands, and tight timelines made traditional procurement routes unworkable. Any delay risked impacting patient recruitment and trial timelines.
"Matrix were highly professional and diligent throughout the engagement. They adhered to every quoted lead time and consistently delivered the highest level of service, playing a key role in the successful execution of our study."
The solution
Matrix sourced the product from Germany through trusted and approved partners, enabling a secure, temperature-controlled supply chain. We managed all supporting documentation including CoAs and Certificates of Origin, and ensured full compliance with Chinese import regulations.
The outcome
Begin your
partnership
with Matrix
